Cargando…
Antipsychotic prescribing to people with dementia during COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577650/ https://www.ncbi.nlm.nih.gov/pubmed/33098796 http://dx.doi.org/10.1016/S1474-4422(20)30370-7 |
| _version_ | 1783598217513926656 |
|---|---|
| author | Howard, Robert Burns, Alistair Schneider, Lon |
| author_facet | Howard, Robert Burns, Alistair Schneider, Lon |
| author_sort | Howard, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7577650 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75776502020-10-22 Antipsychotic prescribing to people with dementia during COVID-19 Howard, Robert Burns, Alistair Schneider, Lon Lancet Neurol Correspondence Elsevier Ltd. 2020-11 2020-10-21 /pmc/articles/PMC7577650/ /pubmed/33098796 http://dx.doi.org/10.1016/S1474-4422(20)30370-7 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Howard, Robert Burns, Alistair Schneider, Lon Antipsychotic prescribing to people with dementia during COVID-19 |
| title | Antipsychotic prescribing to people with dementia during COVID-19 |
| title_full | Antipsychotic prescribing to people with dementia during COVID-19 |
| title_fullStr | Antipsychotic prescribing to people with dementia during COVID-19 |
| title_full_unstemmed | Antipsychotic prescribing to people with dementia during COVID-19 |
| title_short | Antipsychotic prescribing to people with dementia during COVID-19 |
| title_sort | antipsychotic prescribing to people with dementia during covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577650/ https://www.ncbi.nlm.nih.gov/pubmed/33098796 http://dx.doi.org/10.1016/S1474-4422(20)30370-7 |
| work_keys_str_mv | AT howardrobert antipsychoticprescribingtopeoplewithdementiaduringcovid19 AT burnsalistair antipsychoticprescribingtopeoplewithdementiaduringcovid19 AT schneiderlon antipsychoticprescribingtopeoplewithdementiaduringcovid19 |